United States · FDA National Drug Code directory
HYDROMORPHONE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43602-002_b492adee-8ae4-476e-8047-c13fb2136b58
- Product NDC
- 43602-002
- Form
- TABLET
- Composition / generic term
- hydromorphone hydrochloride
- Labeler
- Ascent Pharmaceuticals Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180124
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDROMORPHONE HYDROCHLORIDE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET in 1 BOTTLE (43602-002-05) · 43602-002-05
- 30 TABLET in 1 BOTTLE (43602-002-30) · 43602-002-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →